Use and diagnostic outcomes of cancer patient pathways in Denmark - is the place of initial diagnostic work-up an important factor?

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Use and diagnostic outcomes of cancer patient pathways in Denmark - is the place of initial diagnostic work-up an important factor? / Damhus, Christina Sadolin; Siersma, Volkert; Birkmose, Anna Rubach; Dalton, Susanne Oksbjerg; Brodersen, John.

I: BMC Health Services Research, Bind 22, Nr. 1, 130, 2022.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Damhus, CS, Siersma, V, Birkmose, AR, Dalton, SO & Brodersen, J 2022, 'Use and diagnostic outcomes of cancer patient pathways in Denmark - is the place of initial diagnostic work-up an important factor?', BMC Health Services Research, bind 22, nr. 1, 130. https://doi.org/10.1186/s12913-022-07545-x

APA

Damhus, C. S., Siersma, V., Birkmose, A. R., Dalton, S. O., & Brodersen, J. (2022). Use and diagnostic outcomes of cancer patient pathways in Denmark - is the place of initial diagnostic work-up an important factor? BMC Health Services Research, 22(1), [130]. https://doi.org/10.1186/s12913-022-07545-x

Vancouver

Damhus CS, Siersma V, Birkmose AR, Dalton SO, Brodersen J. Use and diagnostic outcomes of cancer patient pathways in Denmark - is the place of initial diagnostic work-up an important factor? BMC Health Services Research. 2022;22(1). 130. https://doi.org/10.1186/s12913-022-07545-x

Author

Damhus, Christina Sadolin ; Siersma, Volkert ; Birkmose, Anna Rubach ; Dalton, Susanne Oksbjerg ; Brodersen, John. / Use and diagnostic outcomes of cancer patient pathways in Denmark - is the place of initial diagnostic work-up an important factor?. I: BMC Health Services Research. 2022 ; Bind 22, Nr. 1.

Bibtex

@article{6988ce706aa7403c900b071204a2086c,
title = "Use and diagnostic outcomes of cancer patient pathways in Denmark - is the place of initial diagnostic work-up an important factor?",
abstract = "Introduction The Cancer Patient Pathway for Non-specific Symptoms and Signs of Cancer (NSSC-CPP) has been implemented in Denmark with regional and intra-regional differences. In some places, the initial diagnostic work-up (often including a CT scan) is performed by general practitioners (GPs) and in others by hospitals. Variations may influence the use of Organ Specific Cancer Patient Pathways (OS-CPPs) and prognostic outcomes for the patients. Therefore, the aims were: 1) To analyse how a CT scan referred from GP or hospital is followed by OS-CPPs and NSSC-CPPs at the national and regional level, and 2) To analyse, nationally and regionally, the diagnostic outcomes of persons referred to CT scan by either GP or hospital six months after and mortality one year after CT scan. Methods A nationwide population-based study including individuals with a first CT scan in 2013-2016, either referred from GP or hospital. Results Overall, individuals with a CT scan referred from GPs were more likely to start a NSSC-CPP or an OS-CPP than individuals with a CT scan referred by hospitals. Across the five Regions in Denmark, CT scans referred by GPs were associated with reduced odds of total mortality in all regions; (North, OR=0.78 [0.73 0.83], Central, OR=0.92 [0.87 0.96], South, OR=0.85 [0.81 0.89], Capital, OR=0.96 [0.91 1.00] and Zealand, OR=0.85 [0.79 0.90]) and increased odds of cancer-specific mortality in four regions, ORs ranging from 1.15-1.51 with no difference in Region North (1.00 [0.91 1.10]). Conclusion No obvious association between more CT scans and CPPs and reduced diagnoses and mortality was observed. The different diagnostic models might not explain the prognostic outcomes, but the different use of CT scans in, and between Regions play a large role in the differences in incidence and mortality.",
keywords = "Cancer patient pathways, Cancer diagnostics, Prognostic outcomes, Registry-study, NONSPECIFIC SYMPTOMS, DANISH",
author = "Damhus, {Christina Sadolin} and Volkert Siersma and Birkmose, {Anna Rubach} and Dalton, {Susanne Oksbjerg} and John Brodersen",
year = "2022",
doi = "10.1186/s12913-022-07545-x",
language = "English",
volume = "22",
journal = "BMC Health Services Research",
issn = "1472-6963",
publisher = "BioMed Central Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Use and diagnostic outcomes of cancer patient pathways in Denmark - is the place of initial diagnostic work-up an important factor?

AU - Damhus, Christina Sadolin

AU - Siersma, Volkert

AU - Birkmose, Anna Rubach

AU - Dalton, Susanne Oksbjerg

AU - Brodersen, John

PY - 2022

Y1 - 2022

N2 - Introduction The Cancer Patient Pathway for Non-specific Symptoms and Signs of Cancer (NSSC-CPP) has been implemented in Denmark with regional and intra-regional differences. In some places, the initial diagnostic work-up (often including a CT scan) is performed by general practitioners (GPs) and in others by hospitals. Variations may influence the use of Organ Specific Cancer Patient Pathways (OS-CPPs) and prognostic outcomes for the patients. Therefore, the aims were: 1) To analyse how a CT scan referred from GP or hospital is followed by OS-CPPs and NSSC-CPPs at the national and regional level, and 2) To analyse, nationally and regionally, the diagnostic outcomes of persons referred to CT scan by either GP or hospital six months after and mortality one year after CT scan. Methods A nationwide population-based study including individuals with a first CT scan in 2013-2016, either referred from GP or hospital. Results Overall, individuals with a CT scan referred from GPs were more likely to start a NSSC-CPP or an OS-CPP than individuals with a CT scan referred by hospitals. Across the five Regions in Denmark, CT scans referred by GPs were associated with reduced odds of total mortality in all regions; (North, OR=0.78 [0.73 0.83], Central, OR=0.92 [0.87 0.96], South, OR=0.85 [0.81 0.89], Capital, OR=0.96 [0.91 1.00] and Zealand, OR=0.85 [0.79 0.90]) and increased odds of cancer-specific mortality in four regions, ORs ranging from 1.15-1.51 with no difference in Region North (1.00 [0.91 1.10]). Conclusion No obvious association between more CT scans and CPPs and reduced diagnoses and mortality was observed. The different diagnostic models might not explain the prognostic outcomes, but the different use of CT scans in, and between Regions play a large role in the differences in incidence and mortality.

AB - Introduction The Cancer Patient Pathway for Non-specific Symptoms and Signs of Cancer (NSSC-CPP) has been implemented in Denmark with regional and intra-regional differences. In some places, the initial diagnostic work-up (often including a CT scan) is performed by general practitioners (GPs) and in others by hospitals. Variations may influence the use of Organ Specific Cancer Patient Pathways (OS-CPPs) and prognostic outcomes for the patients. Therefore, the aims were: 1) To analyse how a CT scan referred from GP or hospital is followed by OS-CPPs and NSSC-CPPs at the national and regional level, and 2) To analyse, nationally and regionally, the diagnostic outcomes of persons referred to CT scan by either GP or hospital six months after and mortality one year after CT scan. Methods A nationwide population-based study including individuals with a first CT scan in 2013-2016, either referred from GP or hospital. Results Overall, individuals with a CT scan referred from GPs were more likely to start a NSSC-CPP or an OS-CPP than individuals with a CT scan referred by hospitals. Across the five Regions in Denmark, CT scans referred by GPs were associated with reduced odds of total mortality in all regions; (North, OR=0.78 [0.73 0.83], Central, OR=0.92 [0.87 0.96], South, OR=0.85 [0.81 0.89], Capital, OR=0.96 [0.91 1.00] and Zealand, OR=0.85 [0.79 0.90]) and increased odds of cancer-specific mortality in four regions, ORs ranging from 1.15-1.51 with no difference in Region North (1.00 [0.91 1.10]). Conclusion No obvious association between more CT scans and CPPs and reduced diagnoses and mortality was observed. The different diagnostic models might not explain the prognostic outcomes, but the different use of CT scans in, and between Regions play a large role in the differences in incidence and mortality.

KW - Cancer patient pathways

KW - Cancer diagnostics

KW - Prognostic outcomes

KW - Registry-study

KW - NONSPECIFIC SYMPTOMS

KW - DANISH

U2 - 10.1186/s12913-022-07545-x

DO - 10.1186/s12913-022-07545-x

M3 - Journal article

C2 - 35101051

VL - 22

JO - BMC Health Services Research

JF - BMC Health Services Research

SN - 1472-6963

IS - 1

M1 - 130

ER -

ID: 291990727